Abstracts
Showing 815 abstracts.
Using a composite maternal-infant outcome measure to assess the timing of TB preventive therapy in pregnant women
Impact of maternal isoniazid preventive therapy (IPT) timing on acquisition of infant TB infection (TBI) in the IMPAACT P1078/TB APPRISE trial
Conference
Union TB Meeting
Study
P1078
Authors
Adriana Weinberg, IMPAACT P1078/TB APPRISE Study Team, Amita Gupta, Lisa Aaron, Grace Montepiedra, Gerhard Theron, Tsungai Chipato, Carolyne Onyango-Makkumbi, Lynda Stranix-ChibandaQuantitative Adherence In Infants Receiving ARV Syrups: P1115 HFC Experience
Conference
Adherence to HIV Prevention and Treatment Conference
Study
P1115
Authors
T Vhembo, N Mufukari, MF Bwakura-Dangarembizi, TP Mhembere, TG MbengeranwaART ADHERENCE IN PERINATALLY INFECTED INFANTS IN THE P1115 STUDY IN ZIMBABWE
Conference
Adherence to HIV Prevention and Treatment Conference
Study
P1115
Authors
TP Mhembere, MF Bwakura-Dangarembizi, TG Mbengeranwa, T VhemboHigher HIV neutralization breadth in young children than in chronically infected adults
Conference
HIv Research for Prevention
Authors
J Eudailey, Y Fong, J Pollara, K Saunders, C LaBranche, D Montefiori, S Permar, G Fouda, Shuk Hang (Grace) Li, M DennisDiagnostic accuracy of clinical newborn assessment versus ultrasound to define preterm birth: the PROMISE trial
Conference
Society for Maternal-Fetal Medicine's Annual Meeting
Study
1077BF, 1077FF
Authors
T Fenton, D Moodley, C Nakabiito, L Fairlie, MG Fowler, J Stringer, B Chi, K Venkatesh, M FarhadPBPK MODELING OF RILPIVIRINE DURING PREGNANCY
Conference
American Society for Clinical Pharmacology & Therapeutics
Study
P1026S
Authors
Y Yang, J Momper, M Mirochnick, T Johnson, H Sachs for the Antiretrovirals in Pregnancy PBPK Modeling Group, M Gockenbach, M GrimsteinA Physiologically-Based Pharmacokinetic Maternal-Fetal Model of Raltegravir and Dolutegravir
Conference
American Society for Clinical Pharmacology & Therapeutics
Study
P1026S
Authors
T Cressey, M Mirochnick, J van den Anker, B Best, J Momper, X Liu, A DallmannDiverse and extreme entry kinetics among vertically transmitted HIV-1 isolates
Conference
CROI 2019
Authors
G Aldrovandi, N Webb, N TobinPROFICIENCY TESTING SUPPORTS COMBINED ANALYSIS OF DOLUTEGRAVIR PHARMACOKINETIC DATA
Conference
CROI 2019
Study
P1093